Patients with chronic lymphocytic leukemia (CLL) who consistently saw the same oncologist or hematologist experienced significantly fewer emergency room visits and hospitalizations, according to a large real-world study of nearly 6,000 individuals treated with covalent Bruton tyrosine kinase inhibitor (cBTKi) therapy. The post Hospitalizations Fall in Chronic Lymphocytic Leukemia Thanks to Continuity of Care appeared first on European Medical Journal.
